In contrast, CD15 and CD133 have been reported to be expressed on Ptch1 deleted medulloblastoma and have previously been identified as tumour initiation markers in both medulloblastoma and gliomas [25, 28, 29, 50]. The gene discussed is PROM1; the disease is central nervous system cancer.